BioCentury
ARTICLE | Clinical News

Tilarginine acetate injection: Phase III ongoing

May 22, 2006 7:00 AM UTC

A DSMB recommended continuation of the double-blind, placebo-controlled, international Phase III TRIUMPH trial in 658 patients without modification. The recommendation came after data for the first 16...